During the past decade, Mission Hospital conducted 115 clinical trials. In the 10-year time frame, 115 clinical trials started and 147 clinical trials were completed, i.e. on average, 127.8% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 62 clinical trials were completed. i.e. 258.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mission Hospital" #1 sponsor was "Children's Oncology Group" with 100 trials, followed by "National Cancer Institute (NCI)" with 94 trials sponsored, "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored and "Radiation Therapy Oncology Group" with 19 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mission Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 194 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 95 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "Mission Hospital" are "Breast Cancer" (22 trials), "Leukemia" (20 trials), "Recurrent Neuroblastoma" (17 trials), "Refractory Neuroblastoma" (14 trials) and "Refractory Non-Hodgkin Lymphoma" (14 trials). Many other conditions were trialed in "Mission Hospital" in a lesser frequency.

Most popular intervention types in "Mission Hospital" are "Drug" (250 trials), "Other" (157 trials), "Biological" (103 trials), "Procedure" (87 trials) and "Radiation" (84 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (95 trials), "Cyclophosphamide" (41 trials), "Quality-of-Life Assessment" (34 trials), "Doxorubicin Hydrochloride" (30 trials) and "Vincristine Sulfate" (29 trials). Other intervention names were less common.

The vast majority of trials in "Mission Hospital" are 308 trials for "All" genders, 31 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Mission Hospital". undefined are not yet recruiting, 42 are recruiting, 109 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 172 completed trials in Mission Hospital, 2 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Mission Hospital, 10 "Phase 1" clinical trials were conducted, 104 "Phase 2" clinical trials and 168 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 32 trials that are defined as “Not Applicable".